In a recent Nature article, Middleton et al. report the National Lung Matrix trial results where patients with previously treated non-small cell lung cancer (NSCLC) are assigned to personalized therapy based on the results of a 28-gene next-generation sequencing panel test.

Original languageEnglish
Pages (from-to)320-322
Number of pages3
JournalCancer Cell
Issue number3
StatePublished - Sep 14 2020


Dive into the research topics of 'Mastering the Complex Targeted Therapy for Non-small Cell Lung Cancer'. Together they form a unique fingerprint.

Cite this